Drug
Comp360 Psilocybin
Comp360 Psilocybin: highest development phase Phase 2/3, developed by Compass Pathways. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Compass Pathways
Trials
| Drug | Phase | Indication |
|---|---|---|
| COMP360 psilocybin NCT07570654 | Phase 2/3 | PTSD - Post Traumatic Stress Disorder |
Latest
No recent events.
Follow Comp360 Psilocybin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.